Progressive Care Launches Native Remote Patient Monitoring Mobile App and Physician Portal for Remotely Managing Chronic and Transitional Care | Techy Kings

[ad_1]

Progressive Care, Inc.

Progressive Care, Inc.

MIAMI, FL, 2022 November 1 (GLOBE NEWSWIRE) — via NewMediaWire — Progressive Care Inc. (OTCQB: RXMD) (Progressive Care or the Company), a personalized healthcare services and technology company, is pleased to announce the launch of its Remote Patient Monitoring (RPM) mobile apps and patient portal, PharmcoMyRPM, and the PharmcoRPM web portal, which helps for service providers to remotely manage patients’ chronic diseases and transitional care, delivery.

The Company has successfully completed the integration of PharmcoMyRPM Patient Portal and PharmcoRPM Physician Portal, which includes a web platform and a native application available on the AppStore and Google Play. These portals allow staff at Progressive Care subsidiary PharmcoRx to connect patients to the company’s new line of 5G-powered devices to remotely monitor patients’ blood pressure, heart rate, weight, blood glucose and oxygen saturation in real time. Clinicians will also have the ability to integrate with 99% of existing wearable devices, including Apple Health, Garmin and Fitbit, to meet broader patient monitoring needs.

In addition to remote patient monitoring, PharmcoRPM’s physician portal enables the Company to provide chronic care management tracking services, generate billing reports based on time spent providing care, and communicate directly with patients to analyze their progress.

“We want to improve communication between patients and providers in an environment that promotes patient-centered care.” The platform provides a list of care tasks designed to encourage patients to be more active by recording their progress through connected devices,” said PharmcoRx Pharmacy Digital Transformation Manager Carlos Rangel.

According to new research by MarketsandMarkets, the global PTP market is predicted to grow by 2027. will reach 175.2 billion The National Center for Biotechnology Information estimates that approximately 67% of Medicare beneficiaries have two or more chronic conditions, which account for 94% of Medicare spending. The company’s expertise in drug and therapy management and active involvement in data analytics would be directly transferable to the RPM market. Through its analysis, the company has determined that the patients it currently serves are candidates for RPM services and plans to begin working with physicians to include them in remote patient monitoring. The company estimates that it can receive gross billings of approximately $120 per eligible Medicare patient per month for RPM and approximately $100 per month per eligible Medicare patient eligible for CCM (Chronic Care Management).

“The launch of our RPM platform is a big step forward for our company. We believe that our existing patient and physician base will benefit greatly from these tools to achieve positive results. Making informed decisions based on reliable, real-time data is essential for clinicians to operate in the most effective and efficient ways. Progressive Care has set itself apart from its competitors with its commitment to medication and adherence management. Our reputation among healthcare professionals in the field is one of our strongest assets,” said Alan Jay Weisberg, CEO of Progressive Care.

For more information on Progressive Care, visit the company’s website. Join and connect with us on social media:

Progressive Care Inc.
https://www.progressivecareus.com

PharmcoRx Pharmacy
https://www.pharmcorx.com

ClearMetrX
https://www.clearmetrx.com

Forward-looking statements:

The statements made herein are not based on current or historical facts, are forward-looking statements, and are forward-looking statements within the meaning of the 1933 Section 27A of the Securities Act and 1934 In Section 21E of the Securities Exchange Act. statements reflect the Company’s expectations regarding future performance, performance and opportunities, which are subject to significant risks and uncertainties. The words “anticipate,” “believe,” “estimate,” “prospect,” “plan,” “target,” “intend” and “expect” and similar expressions are used herein to refer to Progressive Care Inc., its subsidiaries or its management shall identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and involve numerous risks, uncertainties and other factors that could cause the Company’s actual results, performance, prospects and opportunities to differ materially from those expressed or implied by these forward-looking statements.

Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com

[ad_2]

Source link